𝛼SK or Search

ENTITY

Bristol Myers Squibb Co (BMY US)

236

Analysis

Health Care • United States

Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.

more

Refresh

Exchange Announcement • 30 Jul 2026 19:05

Current Report (Form 8-K | Period ending 2026-07-30)

Exchange Announcement • 30 Jul 2026 08:00

Quarterly Report (Form 10-Q | Period ending 2026-06-30)

Exchange Announcement • 09 May 2026 04:33

S-8 | Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Exchange Announcement • 09 May 2026 04:10

Current Report (Form 8-K | Period ending 2026-05-05)

Exchange Announcement • 30 Apr 2026 23:44

Quarterly Report (Form 10-Q | Period ending 2026-03-31)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x